Real Heart Cash Flow Conversion Efficiency

Latest as of June 2025: -0.026x

Real Heart cash flow conversion efficiency. Based on the latest financial reports, Real Heart (HEART) has a cash flow conversion efficiency ratio of -0.026x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-1.94 Million ≈ $-208.80K USD) by net assets (Skr74.35 Million ≈ $8.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Real Heart (2014–2024)

Cash flow conversion efficiency of Real Heart from 2014 to 2024. This chart illustrates how Real Heart's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Real Heart for real-time trading data and today's change.

Real Heart Cash Flow Conversion Ratio Explained

Real Heart cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Real Heart Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Real Heart ranked by their cash flow conversion efficiency. Also see HEART market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Peppermint Innovation Ltd AU:PIL	0.030x
Platina Resources Ltd AU:PGM	-0.008x
Presurance Holdings, Inc. NASDAQ:PRHI	-0.027x
Intensity Therapeutics, Inc. Common stock NASDAQ:INTS	-0.183x
Danish Aerospace Company A/S CO:DAC	0.428x
Intelicare Holdings Ltd AU:ICR	0.289x
RUGBY RESOURCES LTD F:64O	N/A
Sarama Resource V:SWA	0.351x

Annual Cash Flow Conversion Efficiency for Real Heart (2014–2024)

The table below shows the annual cash flow conversion efficiency of Real Heart from 2014 to 2024. Review HEART free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr67.34 Million ≈ $7.25 Million	Skr-12.99 Million ≈ $-1.40 Million	-0.193x	+36.81%
2023-12-31	Skr82.04 Million ≈ $8.83 Million	Skr-25.05 Million ≈ $-2.70 Million	-0.305x	-304.00%
2022-12-31	Skr97.65 Million ≈ $10.51 Million	Skr-7.38 Million ≈ $-794.22K	-0.076x	+12.86%
2021-12-31	Skr111.29 Million ≈ $11.98 Million	Skr-9.65 Million ≈ $-1.04 Million	-0.087x	+33.92%
2020-12-31	Skr71.69 Million ≈ $7.72 Million	Skr-9.41 Million ≈ $-1.01 Million	-0.131x	-5.77%
2019-12-31	Skr59.00 Million ≈ $6.35 Million	Skr-7.32 Million ≈ $-788.00K	-0.124x	+62.85%
2018-12-31	Skr19.30 Million ≈ $2.08 Million	Skr-6.45 Million ≈ $-693.86K	-0.334x	+6.75%
2017-12-31	Skr27.52 Million ≈ $2.96 Million	Skr-9.86 Million ≈ $-1.06 Million	-0.358x	-66.32%
2016-12-31	Skr16.20 Million ≈ $1.74 Million	Skr-3.49 Million ≈ $-375.55K	-0.215x	+8.16%
2015-12-31	Skr5.97 Million ≈ $642.14K	Skr-1.40 Million ≈ $-150.60K	-0.235x	+0.45%
2014-12-31	Skr7.50 Million ≈ $806.85K	Skr-1.77 Million ≈ $-190.08K	-0.236x	--

About Real Heart

ST:HEART Sweden Medical Devices

Market Cap

$9.12 Million

Skr84.73 Million SEK

Market Cap Rank

#27172 Global

#587 in Sweden

Share Price

Skr16.95

Change (1 day)

+2.73%

52-Week Range

Skr13.15 - Skr23.50

All Time High

Skr1625.78